Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the completion of a 1,600-person clinical study at a prominent University in Indonesia to validate the company's AI-powered non-invasive screening technology to prepare for the regulatory approval application to classify Safe Entry as a medical device.
As the company's commercialization efforts are underway in Indonesia, it said having Safe Entry classified as a medical device is an integral step to scaling into the landscape of the Indonesian market. The third-party validation of the company's AI-powered screening technology marks yet another milestone for the efficacy of Safe Entry, it added.
Toubani Resources Inc. (TSX-V:TRE, ASX:TRE) has released the first set of results from the ongoing drilling program at its Kobada Gold Project in southern Mali which reveal that it has already extended mineralisation by 1 kilometer (km).
The company explained that the drilling was designed to test potential extensions to mineralisation at the Kobada Main Deposit. Extensive artisanal workings can be found along strike and trend from Kobada Main, yet almost no drilling has been undertaken, it said.
Western Magnesium Corp. (TSX-V:WMG, OTCQB:MLYF) has announced that all resolutions proposed were passed at its annual general meeting (AGM) held on Tuesday, March 7, 2023. Shareholders voted in favour of all matters brought before them at the meeting, including the re-election of Edward Lee, Sam Ataya, Steve Thorlakson, Jeff Wilson, and Rabih Ataya to the Board of Directors; the appointment of Adeptus Partners LLC as the company’s auditors; and the stock option plan. The percentage of shares represented at the meeting was 43.73% with a total of 121 shareholders, holding 199,655,955 shares. Due to a technical problem with the Microsoft Teams software, unfortunately, a number of shareholders were not able to access the online meeting. We are working with Microsoft to resolve this issue and once this is resolved we will send an invitation for a follow up discussion.
Vivos Therapeutics (NASDAQ:VVOS) has announced that Kirk Huntsman, its chairman and CEO, and Brad Amman, its CFO, will participate in a fireside chat at the 35th Annual ROTH Conference on Tuesday, March 14, 2023 at 1.30pm PT (4.30pm ET). The conference is being held virtually and in-person in Dana Point, CA from March 12-14, 2023. Huntsman and Amman will participate in the fireside chat with ROTH senior research analyst Scott Henry and conduct one-to-one meetings with investors during the conference. Interested parties can access the live webcast of the fireside chat at a link that will be available on Vivos’ investor relations page at: https://vivos.com/investor-relations.
Genprex, Inc. (NASDAQ:GNPX) has announced its participation in the 35th Annual Roth Conference bring held March 12-14, 2023, at the The Ritz-Carlton, Laguna Niguel, Dana Point, California. In attendance at the Roth Conference will be Genprex's chief financial officer, Ryan Confer, and those interested in meeting him during the conference, can request a meeting through the conference portal or reach out to investor relations at investors@genprex.com. Genprex said it will also participate at BIO-Europe Spring being held March 20 - 22, 2023, at Messe Basel, Basel, Switzerland. In attendance at BIO-Europe Spring will be several members of Genprex's executive leadership team and, again, a meeting can be requested through the conference portal or reach out to investor relations at investors@genprex.com. "We are pleased to have members of our Senior Leadership Team participate in these upcoming conferences as they offer an excellent opportunity to highlight the significant potential for our novel gene therapies to address unmet medical needs in oncology and diabetes," said Rodney Varner, chief executive officer of Genprex. "We look forward to providing an overview and update on our clinical development programs, including our Phase 1 dose escalation portion of the Acclaim-1 Phase 1/2 clinical trial of REQORSA (quaratusugene ozeplasmid) in combination with Tagrisso® (osimertinib) to treat late-stage non-small cell lung cancer and our recent groundbreaking data from a non-human primate study evaluating our innovative gene therapy to treat Type 1 diabetes presented at a global medical meeting."
Harbor Custom Development Inc. (NASDAQ:HCDI) told investors that based on its preliminary results, it does not expect to meet its guidance targets for 2022 of full year revenue and adjusted EBITDA of $61 to $65 million and $(7) million to $(5) million loss, respectively. The primary drivers of the miss were a cancellation of a sale of real estate in Punta Gorda, Florida, which was previously under contract and expected to close in the fourth quarter of 2022; cost overruns associated with two fee build projects that are now in final stages of completion; and an impairment charge that was recorded to one of the company's multi-family properties. Harbor plans to provide full year financial results by March 31, 2023.
Versus Systems Inc. (NASDAQ:VS, CSE:VS) is scheduled to participate in the 35th Annual ROTH Conference, which is being held at The Ritz-Carlton, Laguna Niguel in Dana Point, CA from March 12-14, 2023.mVersus management will be available for one-on-one meetings throughout the day on Tuesday, March 14, 2023. To receive additional information, request an invitation or schedule a one-on-one meeting with management, please contact a ROTH representative or the company’s investor relations team at VS@gatewayir.com.
Century Global Commodities Corp (TSX:CNT) announced that it has received notification that a Receiver is in the process of being appointed with respect to the 24,691,628 of its common shares that are registered in the name of Purple Star Holdings Limited. The company said it understands that the Receiver will be appointed pursuant to a loan for which the shares were pledged as security. It also said it understands that a Form 45-102F1 – Notice of Intention to Distribute Securities under Section 2.8 of NI 45-102 has been filed in respect of these shares. The Receiver is expected to file an early warning report and issue a press release upon its appointment in accordance with securities laws, Century added.
Gold Resource Corporation (NYSE-A:GORO, ETR:GIH) revealed that it has published its inaugural environmental, social and governance (ESG) report and has taken “measurable strides” to ensure “proper care and respect” is extended to its employees, communities, and environment. The Denver-based gold and silver producer noted that the ESG report articulates its efforts in the area and shares the framework it has in place to holds itself “accountable.” The report also outlines its approach to sustainability across key governance, health and safety, social and environmental topics, along with a summary of its 2022 performance and plans. “We are committed to advancing our framework as we mature and refine our approach,” said Gold Resource, while saying that the company’s Don David Gold Mine in Mexico has been making investments in ESG endeavors for over 10 years. “Our Back Forty Project in the Upper Peninsula of Michigan has also invested heavily in ESG, including ensuring our environmental impact assessment is robust and thoughtful in identifying culturally significant sites that will be respected,” it added. The ESG report can be found on the company’s website at: www.goldresourcecorp.com/responsible-mining/esg-reports/.